Provided herein are compositions and methods for treating myelofibrosis in a subject. The methods comprise administering to the subject an effective amount of compound which is which is N-tert-butyl-3-[(5-methyl-2-[4-(2-pyrrolidin-1-ylethoxy)phenyl]amino}pyrimidin-4-yl)amino]benzenesulfonamide or a pharmaceutical salt thereof or a hydrate thereof.
本文提供了用于治疗受试者骨髓纤维化的组合物和方法。这些方法包括向受试者施用有效量的化合物,该化合物是N-叔丁基-3-[(5-甲基-2-[4-(2-
吡咯烷-1-基乙氧基)苯基]
氨基}
嘧啶-4-基)
氨基]苯磺酰胺或其药物盐或其
水合物。